Hypoxia-Activated Pro-Drugs of the KDAC Inhibitor Vorinostat (SAHA) (2019)
Attributed to:
Chemical bioreductive approaches to targeted radiosensitisation and imaging of tumours
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.26434/chemrxiv.9963503.v1
Publication URI: http://dx.doi.org/10.26434/chemrxiv.9963503.v1
Type: Preprint